Disorganization in first episode affective psychosis: Treatment response and clinical considerations from a 2-year follow-up study in a "real world" setting

Span J Psychiatry Ment Health. 2023 Jul-Sep;16(3):151-158. doi: 10.1016/j.rpsm.2021.12.003. Epub 2021 Dec 17.

Abstract

Introduction: Disorganization is a crucial domain in affective psychoses. However, it has received poor research attention, especially at the illness onset. The aims of this study were: (a) to monitor the longitudinal course of disorganization in young people with first episode affective psychosis (FEAP) across 2 years of follow-up, and (b) to investigate any relevant correlation of disorganized symptoms with psychopathology, functioning and the specific treatment elements of an "Early Intervention in Psychosis" (EIP) protocol along the follow-up period.

Materials and methods: Seventy-five FEAP participants (aged 12-35 years) completed the Positive And Negative Syndrome Scale (PANSS) and the Global Assessment of Functioning (GAF). Spearman's rank correlation coefficients were calculated.

Results: During the follow-up, disorganized symptoms showed significant enduring positive correlations with PANSS items representing delusional thought content and uncooperativeness, as well as a persistent negative association with the GAF score. Across the 2-year follow-up period, FEAP individuals also had a relevant reduction in disorganization levels. This symptom decrease was specifically related with the combination of antipsychotic medication with the specific psychosocial components of our EIP intervention offered to FEAP patients during the first 12 months of treatment.

Conclusions: Disorganization is relevant in FEAP subjects already at their enrollment in specialized EIP protocols. However, it decreases over time, together with the delivery of specific, combined (person-tailored) EIP interventions.

Keywords: Affective psychosis; Disorganization; First episode psychosis; Follow-up; Treatment response.

MeSH terms

  • Adolescent
  • Affective Disorders, Psychotic / drug therapy
  • Antipsychotic Agents* / therapeutic use
  • Follow-Up Studies
  • Humans
  • Psychopathology
  • Psychotic Disorders* / diagnosis

Substances

  • Antipsychotic Agents